Asitri Dashboard Search Clinical Trials
The U.S. National Library of Medicine provides a database of clinical trials worldwide. Use the fields below to search the database. Expand your results and select terms or phrases and right-click to search using Google, MalaCards, MedlinePlus, PubMed, or Wikipedia.
Saved Searches
Choose Search
Basic Search
Clinical Trials Search Results
Search History:
Count: 188
Selected: 0
| NCT ID | Title | ||
|---|---|---|---|
| NCT02058706 | LHRH Analogue Therapy With Enzalutamide or Bicalutamide in Treating Patients With Hormone Sensitive Prostate Cancer | ||
| NCT01504711 | Fosaprepitant Dimeglumine in Preventing Nausea and Vomiting in Patients With Gastrointestinal Cancer Receiving Combination Chemotherapy | ||
| NCT05222438 | Trial of Loncastuximab Tesirine in High Risk Diffuse Large B-cell Lymphoma Post Transplant | ||
| NCT00914147 | Lung Function Testing in Patients With Locally Advanced or Metastatic Solid Tumors | ||
| NCT02269267 | The Life After Stopping Tyrosine Kinase Inhibitors Study (The LAST Study) | ||
| NCT00369109 | Skin Biopsies and DNA Analysis in Patients Receiving Irinotecan or Gemcitabine For Advanced Solid Tumors | ||
| NCT00984919 | Biomarker 11-dh-TXB2 in Blood and Urine Samples From Patients With Prostate Cancer and Healthy Volunteers | ||
| NCT00520767 | Bortezomib, Melphalan, and Dexamethasone in Treating Patients With Primary Amyloidosis or Light Chain Deposition Disease | ||
| NCT00897247 | Biomarkers to Detect Mesothelioma Early in Patients Exposed to Asbestos or Vermiculite | ||
| NCT01147016 | Targeted T Cells After Neoadjuvant Chemotherapy in Treating Women With Stage II or III Breast Cancer Undergoing Surgery | ||
| NCT06420167 | DapagliFLOzin in Renal AL Amyloidosis (FLORAL) | ||
| NCT04088786 | Phase I Trial HIPEC With Nal-irinotecan | ||
| NCT00503841 | Erlotinib in Treating Women Undergoing Surgery For Stage I, Stage II, or Stage III Breast Cancer | ||
| NCT04479267 | Polatuzumab Vedotin and Combination Chemotherapy for the Treatment of Previously Untreated Lymphoma | ||
| NCT01468532 | Docetaxel, Prednisone, and Pasireotide in Treating Patients With Metastatic Hormone-Resistant Prostate Cancer | ||
| NCT02819024 | Dexamethasone Effects in Patients With Refractory Non-Small Cell Lung Cancer Using FLT Positron Emission Tomography | ||
| NCT06501040 | Increasing Knowledge and Interest in Cancer Clinical Trials | ||
| NCT00438204 | Pemetrexed Disodium, Gemcitabine, and Bevacizumab in Treating Patients With Stage IIIB or Stage IV Non-Small Cell Lung Cancer | ||
| NCT00005027 | Rebeccamycin Analog in Treating Patients With Advanced Kidney Cancer | ||
| NCT00027807 | Biological Therapy in Treating Women With Stage IV Breast Cancer | ||
| NCT06439914 | First-in-human Study of Interferon-y PET Imaging to Assess Response to Immunotherapy | ||
| NCT00938626 | Treated T Cells Followed by a Stem Cell Transplant in Treating Patients With Multiple Myeloma | ||
| NCT00003626 | Dolastatin 10 in Treating Patients With Metastatic Prostate Cancer That Has Not Responded to Previous Hormone Therapy | ||
| NCT01812668 | Cabozantinib-S-Malate in Treating Patients With Hormone-Resistant Metastatic Prostate Cancer | ||
| NCT02521090 | EGFRBi-Armed Autologous T Cells in Treating Patients With Recurrent or Refractory Glioblastoma | ||
| NCT00244946 | Combination Chemotherapy Followed By Autologous Stem Cell Transplant, and White Blood Cell Infusions in Treating Patients With Non-Hodgkin's Lymphoma | ||
| NCT02145078 | Gene Expression Levels in Predicting Treatment Response in Patients With Stage IV Non-small Cell Lung Cancer | ||
| NCT00305747 | Diindolylmethane in Treating Patients With Nonmetastatic Prostate Cancer That Has Not Responded To Previous Hormone Therapy | ||
| NCT01051570 | Carboplatin, Everolimus, and Prednisone in Treating Patients With Metastatic Prostate Cancer That Progressed After Docetaxel | ||
| NCT00960427 | Studying Biomarkers in Tumor Tissue and Blood Samples From Patients Undergoing Chemotherapy and Radiation Therapy for Stage II or Stage III Rectal Cancer That Can Be Removed By Surgery | ||
| NCT00890617 | Cryotherapy in Treating Patients With Primary Stage I Non-Small Cell Lung Cancer or Lung Metastasis | ||
| NCT00078923 | Soy Isoflavones in Treating Patients Who Are Undergoing Radical Prostatectomy for Stage I or Stage II Adenocarcinoma of the Prostate | ||
| NCT00002923 | KRN5500 in Treating Patients With Metastatic Solid Tumors | ||
| NCT05028374 | COVID-19 VAX Booster Dosing in Patients With Hematologic Malignancies | ||
| NCT00003250 | Fenretinide in Treating Patients With Solid Tumors | ||
| NCT00003174 | Bryostatin 1 Plus Cladribine in Treating Patients With Relapsed Chronic Lymphocytic Leukemia | ||
| NCT00768118 | A Nutritional Supplement Capsule Containing Curcumin, Green Tea Extract, Polygonum Cuspidatum Extract, and Soybean Extract in Healthy Participants | ||
| NCT00030420 | Celecoxib and Docetaxel in Treating Patients With Advanced Non-Small Cell Lung Cancer | ||
| NCT00120029 | Peer Counseling for Weight Loss | ||
| NCT03684005 | MyPatientPal: An App to Help Patients Manage Their Cancer Care | ||
| NCT00030407 | Celecoxib and Docetaxel in Treating Patients With Non-Small Cell Lung Cancer | ||
| NCT01208662 | Randomized Trial of Lenalidomide, Bortezomib, Dexamethasone vs High-Dose Treatment With SCT in MM Patients up to Age 65 | ||
| NCT00258245 | Arsenic Trioxide and Ascorbic Acid Combined With Bortezomib, Thalidomide, and Dexamethasone in Treating Patients With Relapsed or Refractory Multiple Myeloma or Plasma Cell Leukemia | ||
| NCT00003925 | Combination Chemotherapy In Treating Patients With Advanced Cancer | ||
| NCT00514215 | Cryotherapy and GM-CSF in Treating Patients With Lung Metastases or Primary Lung Cancer | ||
| NCT07042191 | A Provider Intervention to Reduce Financial Toxicity in Patients With Cancer Through Improved Treatment Cost Discussions | ||
| NCT02372877 | Evaluation of the AMICUS RBCx System in Sickle Cell Patients | ||
| NCT02178163 | Comprehensive Genomic Analysis in Tissue Samples From Patients With Recurrent or Stage IV Non-small Cell Lung Cancer | ||
| NCT03719677 | Reducing Metabolic Syndrome Among Breast Cancer Survivors | ||
| NCT05025748 | Ask Questions (ASQ):Implementation of a Communication Intervention |
